Compounds > rolofylline
Page last updated: 2024-08-24

rolofylline and Syndrome

rolofylline has been researched along with Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gottlieb, SS1
Dohadwala, MM; Givertz, MM1
Givertz, MM; Slawsky, MT1

Reviews

3 review(s) available for rolofylline and Syndrome

ArticleYear
Adenosine A1 antagonists and the cardiorenal syndrome.
    Current heart failure reports, 2008, Volume: 5, Issue:2

    Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Prognosis; Randomized Controlled Trials as Topic; Receptor, Adenosine A1; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Xanthines

2008
Role of adenosine antagonism in the cardiorenal syndrome.
    Cardiovascular therapeutics, 2008,Winter, Volume: 26, Issue:4

    Topics: Adenosine A1 Receptor Antagonists; Animals; Heart Failure; Hospital Mortality; Humans; Kidney Failure, Chronic; Registries; Syndrome; Xanthines

2008
Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:2

    Topics: Adenosine A1 Receptor Antagonists; Animals; Cardiovascular Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Heart Failure; Humans; Renal Insufficiency, Chronic; Syndrome; Xanthines

2009